Skip to content

Clinical trials

Completed Thrombocythemia, Essential trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Status: Completed Country / region: United States Clear all

91 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20011
20027
20031
20043
20058
20068
20077
20087
20092
20105
20115
20123
20144
20152
20161
20181
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed91

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center12
National Cancer Institute (NCI)11
Icahn School of Medicine at Mount Sinai4
Case Comprehensive Cancer Center3
Eli Lilly and Company3
Memorial Sloan Kettering Cancer Center3
National Institutes of Health Clinical Center (CC)3
Northwestern University3
Alliance for Clinical Trials in Oncology2
California Cancer Consortium2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocythemia, Essential91
Polycythemia Vera81
Primary Myelofibrosis77
Myeloproliferative Disorders65
Precursor Cell Lymphoblastic Leukemia-Lymphoma52
Leukemia, Myeloid, Acute50
Leukemia, Myelomonocytic, Chronic50
Leukemia, Lymphocytic, Chronic, B-Cell49
Multiple Myeloma44
Burkitt Lymphoma43

Trials

Showing 1 to 25 of 91. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.